Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Naranjo

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Science Advances|December 8, 2021
Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2Kristen A Rodrigues, Sergio A Rodriguez-Aponte, Neil C Dalvie, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Science Advances|December 8, 2021
Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2Kristen A Rodrigues, Sergio A Rodriguez-Aponte, Neil C Dalvie, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 2